NCT06195345 Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
| NCT ID | NCT06195345 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Los Angeles |
| Condition | HIE |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-11-01 |
| Primary Completion | 2030-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-11-01 with a primary completion date of 2030-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational study in patients who require clinical anesthesia. The main purpose of this study is to understand whether there are differences in the cerebral blood flow, and oxygen metabolism affected by different types of anesthesia. Subjects who require clinical anesthesia for a clinical MRI and for whom the use of anesthetics for the exam are in clinical equipoise are asked to join the study. All eligible subjects will be asked to provide informed consent before participating in the study.
Eligibility Criteria
Inclusion Criteria: * Individuals who are able to tolerate an MRI. * Are patients scheduled for a clinically indicated MRI. * Between birth and up to 18 years. Exclusion Criteria: * Presence of an MRI-incompatible device or implant (e.g. pacemakers, stents) * Unable to tolerate the enclosed spaces and loud noises for the duration of time in scanner required to obtain an MRI. * Preterm infants less than 25 weeks * Any patient who is clinically too unstable to extend their MRI by up-to 7.5 minutes.
Contact & Investigator
Matthew Borzage, PhD
PRINCIPAL INVESTIGATOR
Children's Hospital Los Angeles
Frequently Asked Questions
Who can join the NCT06195345 clinical trial?
This trial is open to participants of all sexes, aged 1 Minute or older, up to 18 Years, studying HIE. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06195345 currently recruiting?
Yes, NCT06195345 is actively recruiting participants. Contact the research team at hwiseman@chla.usc.edu for enrollment information.
Where is the NCT06195345 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT06195345 clinical trial?
NCT06195345 is sponsored by Children's Hospital Los Angeles. The principal investigator is Matthew Borzage, PhD at Children's Hospital Los Angeles. The trial plans to enroll 1,000 participants.